14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.23 $7.87 Thursday, 2nd May 2024 ARDX stock ended at $6.79. This is 2.72% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.75% from a day low at $6.53 to a day high of $6.84.
90 days $6.23 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
May 04, 2023 $4.43 $4.75 $4.23 $4.70 8 016 298
May 03, 2023 $4.50 $4.69 $4.45 $4.68 4 838 650
May 02, 2023 $4.76 $4.74 $4.36 $4.44 6 037 179
May 01, 2023 $4.51 $4.73 $4.47 $4.65 4 188 720
Apr 28, 2023 $4.57 $4.57 $4.40 $4.46 3 698 787
Apr 27, 2023 $4.68 $4.71 $4.37 $4.52 5 353 855
Apr 26, 2023 $4.65 $4.76 $4.57 $4.66 3 070 698
Apr 25, 2023 $4.70 $4.79 $4.58 $4.61 2 758 554
Apr 24, 2023 $5.00 $5.00 $4.66 $4.72 3 995 682
Apr 21, 2023 $4.82 $5.00 $4.79 $4.95 5 869 634
Apr 20, 2023 $4.85 $4.89 $4.77 $4.78 3 531 098
Apr 19, 2023 $4.82 $4.96 $4.75 $4.90 3 737 593
Apr 18, 2023 $5.04 $5.04 $4.79 $4.89 5 173 038
Apr 17, 2023 $4.67 $5.13 $4.63 $4.92 8 077 943
Apr 14, 2023 $4.73 $4.81 $4.56 $4.71 3 623 769
Apr 13, 2023 $4.54 $4.86 $4.51 $4.78 5 943 098
Apr 12, 2023 $4.67 $4.69 $4.45 $4.50 4 453 998
Apr 11, 2023 $4.29 $4.68 $4.27 $4.60 6 613 087
Apr 10, 2023 $4.40 $4.40 $4.19 $4.26 6 084 182
Apr 06, 2023 $4.42 $4.46 $4.31 $4.40 3 017 770
Apr 05, 2023 $4.52 $4.63 $4.38 $4.43 3 597 298
Apr 04, 2023 $4.80 $4.89 $4.48 $4.51 5 512 238
Apr 03, 2023 $4.91 $4.91 $4.58 $4.72 6 400 712
Mar 31, 2023 $4.66 $4.94 $4.62 $4.79 7 685 910
Mar 30, 2023 $4.75 $4.78 $4.55 $4.59 5 832 587
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT